D&C Biotechnologies Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 9

D&C Biotechnologies General Information

Description

Operator of a biotechnology company intended to develop urine chemistry analysis alternatives. The company aims to solve the problem of contamination, infection, and inconvenience of the test process of the existing urine test method used in medical settings around the world, enabling medical personnel to easily undertake tests while ensuring convenience and safety.

Contact Information

Website
www.dncbiotechnology.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 511 Tipstown, Daejeon
  • 99 Daehak-ro, Yuseong-gu
  • Daejeon
  • South Korea
+82
Primary Industry
Diagnostic Equipment
Other Industries
Enterprise Systems (Healthcare)
Vertical(s)
Life Sciences
Corporate Office
  • 511 Tipstown, Daejeon
  • 99 Daehak-ro, Yuseong-gu
  • Daejeon
  • South Korea
+82

D&C Biotechnologies Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

D&C Biotechnologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 01-Mar-2026 Completed Generating Revenue
4. Accelerator/Incubator 01-Jan-2024 Completed Generating Revenue
3. Accelerator/Incubator 16-Jul-2023 Completed Generating Revenue
2. Early Stage VC 04-Jul-2023 $771K $1.17M Completed Generating Revenue
1. Seed Round 01-Feb-2023 $402K $402K Completed Startup
To view D&C Biotechnologies’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

D&C Biotechnologies Patents

  • 6

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • Pending

  • Expiring in next 12 mo

D&C Biotechnologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025100774-A1 Portable urine analysis device Inactive 08-Nov-2023
WO-2025048063-A1 Urine analysis device Inactive 29-Aug-2023
WO-2025100775-A1 Urinalysis device Inactive 13-Dec-2022
WO-2024085599-A1 Urine analysis device and method Inactive 17-Oct-2022
WO-2024035239-A1 Urine analysis device and method Inactive 10-Aug-2022 G01N21/78
To view D&C Biotechnologies’s complete patent history, request access »

D&C Biotechnologies Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

D&C Biotechnologies Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
iAccel (Seongnam-si) Venture Capital Minority
SKTCH Accelerator/Incubator
Tech Incubator Program for Startup Accelerator/Incubator
Hallym University Technology Holdings Venture Capital Minority
Quantam Finance and Acquisition Corporation Minority
You’re viewing 5 of 9 investors. Get the full list »

Ready to get started?

Request a free trial

D&C Biotechnologies FAQs

  • When was D&C Biotechnologies founded?

    D&C Biotechnologies was founded in 2021.

  • Where is D&C Biotechnologies headquartered?

    D&C Biotechnologies is headquartered in Daejeon, South Korea.

  • What is the size of D&C Biotechnologies?

    D&C Biotechnologies has 6 total employees.

  • What industry is D&C Biotechnologies in?

    D&C Biotechnologies’s primary industry is Diagnostic Equipment.

  • Is D&C Biotechnologies a private or public company?

    D&C Biotechnologies is a Private company.

  • What is D&C Biotechnologies’s current revenue?

    The current revenue for D&C Biotechnologies is .

  • How much funding has D&C Biotechnologies raised over time?

    D&C Biotechnologies has raised $1.17M.

  • Who are D&C Biotechnologies’s investors?

    iAccel (Seongnam-si), SKTCH, Tech Incubator Program for Startup, Hallym University Technology Holdings, and Quantam Finance and Acquisition are 5 of 9 investors who have invested in D&C Biotechnologies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process